Pancrelipase Capsules6505-01-100-5017

NSN 6505-01-100-5017 · NIIN 011005017

FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment

Government record, cited

Also searched as 6505-01-100-5017 · 6505011005017 · NIIN 011005017 · 01-100-5017 · FSC 6505 Drugs and Biologicals · COTAZYM · NDC00052-0381-95 · COTAZYM TABLETS

Nearby stock numbers ← 6505-01-100-5016 · 6505-01-100-6405 Urea Lotion →

Features

Pancrelipase Capsules — FSC 6505
Administration: ORAL
Medical Designation and Grade: UNITED STATES PHARMACOPEIA
Primary Container Type: BOTTLE
Capsule Primary Container Content Quantity: 500.000

Identification

NSN: 6505-01-100-5017
NIIN: 011005017
FSC: 6505 — Drugs and Biologicals
FSG: 65 — Medical, Dental, and Veterinary Equipment

General Description

The Pancrelipase Capsules, cataloged under National Stock Number 6505-01-100-5017, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.

Technical Specifications

Parameter	Value
NSN	6505-01-100-5017
Item Name	Pancrelipase Capsules
FSC / FSG	6505 / 65 — Drugs and Biologicals
Status	ACTIVE
Administration	ORAL
Medical Designation and Grade	UNITED STATES PHARMACOPEIA
Primary Container Type	BOTTLE
Capsule Primary Container Content Quantity	500.000

Lifecycle & Compliance

Acquisition Status	ACTIVE
DEMIL Code	DEMIL A — No Demilitarization Required
Hazard	Possible hazard — SDS may be required (DLA HMIC P)
Criticality Code	X

Cross-Reference Index

No manufacturer part numbers on file in the U.S. Government catalog.

Reference documents

Reference	Meaning
COTAZYM	5/9 Secondary reference Organon Usa Inc
NDC00052-0381-95	3/9 Design control — primary reference Organon Usa Inc
COTAZYM TABLETS	5/9 Secondary reference Organon Usa Inc

No interchangeability data on file.

Other items in FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073

6505-00-000-0073 · Item name not on file

6505-00-000-0110

6505-00-000-0110 · Item name not on file

6505-00-000-0134

6505-00-000-0134 · Item name not on file

6505-00-000-0135

6505-00-000-0135 · Item name not on file

6505-00-001-3344

6505-00-001-3344 · Item name not on file

6505-00-001-3345

FLUORESCEIN SODIUM AND BENOXINAT

6505-00-001-3346

6505-00-001-3346 · Item name not on file

6505-00-001-3347

6505-00-001-3347 · Item name not on file

Frequently Asked Questions

What is NSN 6505-01-100-5017?

NSN 6505-01-100-5017 is a Pancrelipase Capsules, classified under FSC 6505, Drugs and Biologicals. Status: active.

What are the specifications of 6505-01-100-5017?

Key specifications for 6505-01-100-5017: Administration: ORAL; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Special Features: ACTIVE MEDICAMENT MEDICINAL STRENGTH:30000.000 MILLIGRAMS OF AMYLASE ACTIVE INGREDIENTS;8000.000 MILLIGRAMS OF LIPASE ACTIVE INGREDIENTS;30000.000 MILLIGRAMS OF PROTEASE ACTIVE INGREDIENTS. 4 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-100-5017 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.

PartsTable Design LLC · partstable.com